These conflicting observations in innate and acquired immunity highlight the crossover between tumor proliferation, antitumor immunity and autoimmunity suggesting that the predominant effects may be determined by the context in which CD24 is engaged as well as by glycosylation of CD24 (16). This evidence concerns the gene CD24 and Autoimmunity.